utilized CRT mRNA in combination with EVs containing anti‐CD3/CD28 fragments, which interacted with CD3/CD28/TCR on the surface of T cells to activate T cells to accomplish CRT high expression in T cells and obtain a better effect on killing tumor cells [129]. This evidence concerns the gene CD28 and neoplasm.